GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
G

GeneDx Holdings WGS · USD

Health Care · US listing · 🇺🇸 United States

Compare

65.72

+5.37%

Close of 9 Nov 2026, in USD

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

Latest on GeneDx Holdings

Our reporting

Next results

9 Nov 2026

Due on 9 Nov 2026. Analysts expect earnings of 0.07 a share on revenue of $122.9m.

Past results

Reported against what analysts expected

3 Aug 20264 May 202623 Feb 202628 Oct 202529 Jul 202530 Apr 2025
Earnings per share0.01-0.280.140.490.500.28
Forecast-0.19-0.060.110.280.100.11
Revenue$114.4m$102.3m$121.0m$116.7m$102.7m$87.1m
Forecast$111.0m$112.5m$120.3m$120.5m$98.6m$85.3m

Key events

  1. 4 May 202333-to-1 reverse split
  2. 23 Jul 20211-to-1 reverse split
  3. 4 Sept 2020Listed

GeneDx Holdings in the news

Headlines from other publishers, linked to their own pages.

Sources and methodology

Data on this tab
Our reporting and our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.